OSCR
Oscar Health·NYSE
--
--(--)
--
--(--)
5.80 / 10
Netural
Analyst consensus is neutral, with two analysts rating OSCR unchanged and a weighted rating of 3.8, reflecting pessimistic market expectations amid a 9.5% price drop. Fund flow is good (7.8/10), showing net inflows, especially from small investors, but overall trend remains negative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionBarclays
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for OSCR?
- OSCR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.80/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
